Pulse Biosciences, Inc.PLSENASDAQ

Revenue (LTM)

$350000

Net Income (LTM)

$-73M

-35.8% YoY

Free Cash Flow

$-54M

Revenue CAGR (5Y)

-29.5%

Marginsdeclining

FCF($0.1B)

Unprofitable

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Revenue	1	1↓50.6%	0	0	0
Gross Profit	-1	-11↓1944.4%	-1↑89.3%	0	-1
Operating Income	-63	-58↑7.9%	-44↑24.9%	-56↓29.1%	-77↓36.8%
Net Income	-64	-59↑8.1%	-42↑27.9%	-54↓26.9%	-73↓35.8%
EBITDA	-62	-57↑8.4%	-42↑25.3%	-55↓30.0%	-72↓30.2%
EPS Diluted	-2.28	-1.72↑24.6%	-0.88↑48.8%	-0.92↓4.5%	-1.08↓17.4%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Cash & Equivalents	29	61↑113.7%	44↓27.4%	118↑166.1%	81↓31.6%
Total Current Assets	37	62↑69.7%	45↓27.1%	119↑163.5%	83↓30.2%
Total Assets	54	78↑43.6%	59↓24.0%	132↑123.9%	96↓27.4%
Total Current Liabilities	9	6↓29.8%	7↑12.2%	10↑49.9%	8↓21.2%
Total Liabilities	19	80↑331.7%	15↓81.5%	18↑19.0%	15↓12.2%
Total Equity	36	-2↓106.3%	44↑2073.3%	115↑158.9%	81↓29.8%
Total Debt	11	76↑575.2%	9↓88.0%	9↓2.7%	8↓15.4%
Net Debt	-17	15↑185.3%	-35↓337.7%	-109↓209.9%	-73↑32.9%

Metric	Dec 21	Dec 22	Dec 23	Dec 24	Dec 25
Operating Cash Flow	-54	-47↑13.1%	-33↑29.7%	-36↓10.0%	-54↓48.9%
Capital Expenditure	-0	-0↑8.2%	-0↑69.8%	-0↓3.3%	-0↓152.0%
Free Cash Flow	-55	-47↑13.1%	-33↑30.1%	-36↓10.0%	-54↓49.3%
Stock-Based Comp	15	5↓64.4%	7↑38.3%	14↑89.2%	21↑57.9%
Net Change in Cash	16	33↑101.4%	-17↓151.6%	74↑539.2%	-37↓150.6%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance